Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
DrugCard is an AI-powered pharmacovigilance platform designed to help pharmaceutical companies, CROs, and drug safety teams automate routine PV processes and manage safety information more efficiently. The platform brings together global and local literature monitoring, regulatory intelligence, and adverse event management in one connected workflow.
DrugCard supports PV teams in identifying relevant safety information faster, reducing manual screening workload, and maintaining transparent, audit-ready processes. Its literature monitoring module covers 121+ countries, 2,200+ local medical sources, and 100+ languages, including both global databases such as PubMed and local, non-indexed medical journals.
The platform uses AI to support article pre-assessment, generate structured summaries, highlight relevant keywords, assist with translations, and help users prioritize publications that may require safety review. DrugCard also provides configurable workflows, automated notifications, reporting tools, QC functionality, audit trails, and case creation from literature.
With additional modules for Regulatory Intelligence and Adverse Event Database management, DrugCard helps organizations track health authority updates, centralize safety data, support E2B workflows, and improve overall pharmacovigilance operations. Built for MAHs, QPPVs, LQPPVs, CROs, regulatory teams, and PV professionals, DrugCard combines automation with human expert oversight to support compliant, scalable, and reliable drug safety management.
Description
Rhizome serves as an AI regulatory collaborator specifically designed for teams in the life sciences sector. While general AI assistants offer remarkable capabilities, there are distinct requirements for an AI tool that aids in making decisions regarding drugs or devices worth over $100 million.
Our agents are strictly limited to referencing facts derived from primary source documents, ensuring that nothing is validated based on agent memory; we assess their performance based on this criterion, and there have been no instances of inaccuracies reported in the past 18 months.
The databases that underpin regulatory decisions, including Drugs@FDA, guidance documents, clinicaltrials.gov, and various standards, often exist in formats that are not easily searchable by computers, with a significant amount being image-only PDFs. We have developed the ability to ingest and process all of this information, encompassing over 75 health authority databases across more than 12 markets as of August 2026, with this number continually growing. This equates to over 45 million documents that our agents can query comprehensively.
In contrast to a general assistant, which typically references 5 to 10 sources, Rhizome is capable of examining hundreds to thousands of documents, as the essential question is often, "Did we overlook a precedent?" This thorough approach ensures that our users are equipped with the most comprehensive and accurate information possible.
API Access
Has API
API Access
Has API
Screenshots View All
No images available
Integrations
No details available.
Integrations
No details available.
Pricing Details
individual
Free Trial
Free Version
Pricing Details
$0/month/user
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
DrugCard
Founded
2021
Country
Estonia
Website
drug-card.io
Vendor Details
Company Name
Rhizome AI
Founded
2023
Country
United States
Website
rhizomeai.com